Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Amplify Weight Loss Drug & Treatment ETF THNR

Full chart Compare
Set alert

Price alert · THNR

All alert types
25.92 USD +0.17 (+0.67%)

At closeNov 6, 2026, 4:04 PM EST

25.92 0.00 0.00%

After hours · Nov 6, 4:04 PM ET

25.66 Day range 25.92
23.48 52-week range 27.91
YTD
+2.76%
1 year
+10.28%

Amplify Weight Loss Drug & Treatment ETF

Issuer
Amplify
Asset class
Equity
Expense ratio
0.59%
Assets under management
$5.15M
NAV
25.75
Holdings
20
Inception
2024-05-21
Top 10 weight
65.45%

Top holdings

  1. LLY Eli Lilly & Co 11.49%
  2. NVO Novo Nordisk A/S 8.72%
  3. AMGN Amgen Inc 6.12%
  4. AZN AstraZeneca PLC 5.93%
  5. REGN Regeneron Pharmaceuticals Inc 5.79%
  6. GILD Gilead Sciences Inc 5.69%
  7. ROP.SW Roche Holding AG 5.66%
  8. ABBV AbbVie Inc 5.65%
  9. PFE Pfizer Inc 5.40%
  10. 4519.T Chugai Pharmaceutical Co Ltd 5.01%
  11. MRK Merck & Co Inc 5.01%
  12. 1093.HK CSPC Pharmaceutical Group Ltd 4.73%
  13. 1801.HK Innovent Biologics Inc 4.49%
  14. VKTX Viking Therapeutics Inc 4.12%
  15. ARWR Arrowhead Pharmaceuticals Inc 3.47%
  16. ZEAL.CO Zealand Pharma A/S 3.24%
  17. 128940.KS Hanmi Pharm Co Ltd 3.19%
  18. 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd 2.43%
  19. GPCR Structure Therapeutics Inc 2.09%
  20. KLRA Kailera Therapeutics Inc 1.09%
  21. AGPXX Invesco Government & Agency Portfolio 12/31/2031 0.36%
  22. Cash & Other 0.33%

Sector weights

  • Healthcare 99.55%
  • Financial Services 0.26%
  • Cash & Others 0.19%

Country weights

  • United States 57.22%
  • Denmark 12.08%
  • China 11.03%
  • United Kingdom 5.90%
  • Switzerland 5.73%
  • Japan 5.14%
  • South Korea 2.89%

Updated 2026-11-07